CV outcomes better with SGLT2 inhibitor than DPP4 inhibitor in T2DM studyNovember 4, 2017DiabetesLipid DisordersHeart Failure
Drug-eluting balloon is as good as drug-eluting stent for in-stent restenosisNovember 1, 2017Interventional Cardiology & SurgeryCAD & AtherosclerosisLipid Disorders
Insurance approvals are hard to get for new PCSK9 inhibitorsOctober 30, 2017CAD & AtherosclerosisLipid DisordersBusiness of Medicine
PCI advances produce CABG-like 1-year outcomesOctober 23, 2017Interventional Cardiology & SurgeryLipid Disorders
Hyperlipidemia diagnosis protects against breast cancerOctober 11, 2017Lipid DisordersCAD & Atherosclerosis
CDC: Forty percent of cancers linked to overweight or obesityOctober 10, 2017Preventive CareLipid Disorders
LDL levels below 10 mg/dL shown safe, effectiveOctober 5, 2017Lipid DisordersCAD & AtherosclerosisStrokeThrombosis
Alcohol showed no cardiovascular benefits in nonalcoholic fatty liver diseaseOctober 1, 2017Lipid DisordersPreventive CareCAD & AtherosclerosisHypertension
Empagliflozin’s effects independent of CVD risk factorsSeptember 27, 2017DiabetesLipid DisordersHeart Failure
Higher BP targets suggested for elderly, cognitively impairedSeptember 27, 2017Lipid DisordersHypertensionStrokeCAD & Atherosclerosis
RAS derangement linked to CVD risk in adolescents born pretermSeptember 23, 2017PediatricsHypertensionLipid Disorders
Lomitapide manufacturer will plead guilty to two misdemeanor charges of misbrandingSeptember 23, 2017Lipid Disorders
